D75.81 - Myelofibrosis
- Applicable to Myelofibrosis
- The 2025 edition of ICD10-CM D75.81 became effective on October 1, 2024.
- This is the American ICD10-CM version of D75.81 - other international versions of ICD10 D75.81 may differ.
- D75.81 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code Additional Code:
- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Type 1 Excludes
- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
codefirst
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Billable/Specific Code
The following codes above D75.81 contain annotation back-references that may be applicable to D75.81:
- Chapter: D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Section: D70-D77 - Other disorders of blood and blood-forming organs
- Category: D75 - Other and unspecified diseases of blood and blood-forming organs
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com